Mark Swanson
Corporate Officer/Principal chez Gel Med Sciences, Inc.
Postes actifs de Mark Swanson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gel Med Sciences, Inc.
 Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - | - |
| Directeur Technique/Scientifique/R&D | 04/01/2010 | - |
Historique de carrière de Mark Swanson
Anciens postes connus de Mark Swanson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
DNX Transgenic Sciences
 DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million. | Corporate Officer/Principal | - | - |
| Sandoz Pharmaceuticals Corp. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Mark Swanson
| University of Connecticut | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Gel Med Sciences, Inc.
Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
DNX Transgenic Sciences
DNX Transgenic Sciences Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., DNX Transgenic Sciences is an American company that provides contract research services and transgenic animal technologies to the biomedical research community. The company is based in NJ. DNX Transgenic Sciences was acquired by Xenogen Corp., a subsidiary of Revvity, Inc. from Nordion (Canada), Inc. on November 13, 2000 for $35 million. | Commercial Services |
- Bourse
- Insiders
- Mark Swanson
- Expérience
